The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Glutamate, Glutamate Receptors, and Downstream Signaling Pathways
Open accessAbstract
Glutamate is a nonessential amino acid, a major bioenergetic substrate for proliferating normal and neoplastic cells, and an excitatory neurotransmitter that is actively involved in biosynthetic, bioenergetic, metabolic, and oncogenic signaling pathways. Glutamate signaling activates a family of receptors consisting of metabotropic glutamate receptors (mGluRs) and ionotropic glutamate receptors (iGluRs), both of which have been implicated in chronic disabling brain disorders such as Schizophrenia and neurodegenerative diseases like Alzheimer's, Parkinson's, and multiple sclerosis. In this review, we discuss the structural and functional relationship of mGluRs and iGluRs and their downstream signaling pathways. The three groups of mGluRs, the associated second messenger systems, and subsequent activation of PI3K/Akt, MAPK, NFkB, PLC, and Ca/CaM signaling systems will be discussed in detail. The current state of human mGluR1a as one of the most important isoforms of Group I-mGluRs will be highlighted. The lack of studies on the human orthologues of mGluRs family will be outlined. We conclude that upon further study, human glutamate-initiated signaling pathways may provide novel therapeutic opportunities for a variety of non-malignant and malignant human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
Conn, P. J., & Pin, J.-P. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,081
Oxidative Medicine and Cellular Longevity
(2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2572 · Cited by 2,393
The metabotropic glutamate receptors: Structure and functions
Pin, J.-P., & Duvoisin, R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00129-g · Cited by 2,266
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Niswender, C. M., & Conn, P. J. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145533 · Cited by 1,892
Advances in Experimental Medicine and Biology
Lunt, G. G. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90020-3 · Cited by 1,851
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
Dong, X.-X., Wang, Y., & Qin, Z.-H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.24 · Cited by 1,297
Sequence and expression of a metabotropic glutamate receptor
Masu, M., Tanabe, Y., Tsuchida, K., Shigemoto, R., & Nakanishi, S. (1991) · Nature · doi:10.1038/349760a0 · Cited by 1,216
Coupling of mGluR/Homer and PSD-95 Complexes by the Shank Family of Postsynaptic Density Proteins
Tu, J. C., Xiao, B., Naisbitt, S., Yuan, J. P., Petralia, R. S., Brakeman, P., Doan, A., Aakalu, V. K., Lanahan, A. A., Sheng, M., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80810-7 · Cited by 1,050
A time-efficient, linear-space local similarity algorithm
Huang, X., & Miller, W. (1991) · Advances in Applied Mathematics · doi:10.1016/0196-8858(91)90017-d · Cited by 1,004
Tu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80589-9 · Cited by 862
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
Mehta, A., Prabhakar, M., Kumar, P., Deshmukh, R., & Sharma, P. L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.032 · Cited by 665
Xiao, B., Tu, J. C., Petralia, R. S., Yuan, J. P., Doan, A., Breder, C. D., Ruggiero, A., Lanahan, A. A., Wenthold, R. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80588-7 · Cited by 647
Glutamate release promotes growth of malignant gliomas
Takano, T., Lin, J. H.-C., Arcuino, G., Gao, Q., Yang, J., & Nedergaard, M. (2001) · Nature Medicine · doi:10.1038/nm0901-1010 · Cited by 601
Park, E., Velumian, A. A., & Fehlings, M. G. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041269641 · Cited by 580
Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer
Romano, C., Yang, W.-L., & O'Malley, K. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28612 · Cited by 536
Aramori, I., & Nakanishi, S. (1992) · Neuron · doi:10.1016/0896-6273(92)90096-v · Cited by 535
Cloning, Expression, and Gene Structure of a G Protein-Coupled Glutamate Receptor from Rat Brain
Houamed, K. M., Kuijper, J. L., Gilbert, T. L., Haldeman, B. A., O'Hara, P. J., Mulvihill, E. R., Almers, W., & Hagen, F. S. (1991) · Science · doi:10.1126/science.1656524 · Cited by 524
Antioxidant therapies in traumatic brain and spinal cord injury
Bains, M., & Hall, E. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.017 · Cited by 428
Molecular Pathways Linking Inflammation and Cancer
Mantovani, A. (2010) · Current Molecular Medicine · doi:10.2174/156652410791316968 · Cited by 414
Hermans, E., & Challiss, R. A. J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590465 · Cited by 404
Kim, K., Lee, S., Kegelman, T. P., Su, Z., Das, S. K., Dash, R., Dasgupta, S., Barral, P. M., Hedvat, M., Diaz, P., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22609 · Cited by 395
Kinkade, C. W., Castillo-Martin, M., Puzio-Kuter, A., Yan, J., Foster, T. H., Gao, H., Sun, Y., Ouyang, X., Gerald, W. L., Cordon-Cardo, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34764 · Cited by 391
G-protein-coupled receptors at a glance
Kroeze, W. K., Sheffler, D. J., & Roth, B. L. (2003) · Journal of Cell Science · doi:10.1242/jcs.00902 · Cited by 380
Rebola, N., Lujan, R., Cunha, R. A., & Mulle, C. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.023 · Cited by 376
Structures of the extracellular regions of the group II/III metabotropic glutamate receptors
Muto, T., Tsuchiya, D., Morikawa, K., & Jingami, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611577104 · Cited by 370
Shiraishi‐Yamaguchi, Y., & Furuichi, T. (2007) · Genome biology · doi:10.1186/gb-2007-8-2-206 · Cited by 345
Progress in Neuro-Psychopharmacology & Biological Psychiatry
Goldman, D. A., & Cohen, P. R. (2012) · Cited by 305
PI3 kinase enhancer–Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis
Rong, R., Ahn, J.-Y., Huang, H., Nagata, E., Kalman, D., Kapp, J. A., Tu, J., Worley, P. F., Snyder, S. H., & Ye, K. (2003) · Nature Neuroscience · doi:10.1038/nn1134 · Cited by 286
Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons
Fagni, L., Chavis, P., Ango, F., & Bockaert, J. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01492-7 · Cited by 281
TOR complex 2: a signaling pathway of its own
Cybulski, N., & Hall, M. N. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.004 · Cited by 265
Regulation of mitogen‐activated protein kinases by glutamate receptors
Wang, J. Q., Fibuch, E. E., & Mao, L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04208.x · Cited by 239
The Calcium-Sensing Receptor: A Molecular Perspective
Magno, A. L., Ward, B. K., & Ratajczak, T. (2011) · Endocrine Reviews · doi:10.1210/er.2009-0043 · Cited by 232
Structural Basis for a Ca 2+ -Sensing Function of the Metabotropic Glutamate Receptors
Kubo, Y., Miyashita, T., & Murata, Y. (1998) · Science · doi:10.1126/science.279.5357.1722 · Cited by 217
Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis
Dhami, G. K., & Ferguson, S. S. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.008 · Cited by 208
Metabotropic glutamate receptor-dependent long-term potentiation
Anwyl, R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.01.002 · Cited by 201
Pin, J. P., Joly, C., Heinemann, S. F., & Bockaert, J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06267.x · Cited by 195
Molecular pathways and targets in cancer-related inflammation
Mantovani, A., Garlanda, C., & Allavena, P. (2010) · Annals of Medicine · doi:10.3109/07853890903405753 · Cited by 185
Julio-Pieper, M., Flor, P. J., Dinan, T. G., & Cryan, J. F. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004036 · Cited by 184
El Moustaine, D., Granier, S., Doumazane, E., Scholler, P., Rahmeh, R., Bron, P., Mouillac, B., Banères, J.-L., Rondard, P., & Pin, J.-P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205838109 · Cited by 173
G-protein-independent signaling mediated by metabotropic glutamate receptors
Heuss, C., Scanziani, M., Gähwiler, B. H., & Gerber, U. (1999) · Nature Neuroscience · doi:10.1038/15996 · Cited by 171
Francesconi, A., & Duvoisin, R. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5615 · Cited by 170
A Requirement for Nuclear Factor-κB in Developmental and Plasticity-Associated Synaptogenesis
Boersma, M. C. H., Dresselhaus, E. C., De Biase, L. M., Mihalas, A. B., Bergles, D. E., & Meffert, M. K. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2456-10.2011 · Cited by 168
Structure of the Homer EVH1 Domain-Peptide Complex Reveals a New Twist in Polyproline Recognition
Beneken, J., Tu, J. C., Xiao, B., Nuriya, M., Yuan, J. P., Worley, P. F., & Leahy, D. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)81145-9 · Cited by 168
NF-κB signalling regulates the growth of neural processes in the developing PNS and CNS
Gutierrez, H., Hale, V. A., Dolcet, X., & Davies, A. (2005) · Development · doi:10.1242/dev.01702 · Cited by 167
Gomeza, J., Joly, C., Kuhn, R., Knöpfel, T., Bockaert, J., & Pin, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2199 · Cited by 161
Koochekpour, S., Majumdar, S., Azabdaftari, G., Attwood, K. M., Scioneaux, R., Subramani, D., Manhardt, C. T., Lorusso, G. D., Willard, S. S., Thompson, H., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1308 · Cited by 160
Self-citationGroup I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
Ribeiro, F. M., Paquet, M., Cregan, S. P., & Ferguson, S. S. G. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361612 · Cited by 159
Autism, Alzheimer disease, and fragile X
Sokol, D. K., Maloney, B., Long, J. M., Ray, B., & Lahiri, D. K. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166dc7 · Cited by 141
Molecular Pathways: Dysregulated Glutamatergic Signaling Pathways in Cancer
Prickett, T. D., & Samuels, Y. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1217 · Cited by 131
Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease
Jaiswal, M. K., Zech, W., Goos, M., Leutbecher, C., Ferri, A., Zippelius, A., Carrì, M. T., Nau, R., & Keller, B. U. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-64 · Cited by 122
Sokol, D. K., Chen, D., Farlow, M. R., Dunn, D. W., Maloney, B., Zimmer, J. A., & Lahiri, D. K. (2006) · Journal of Child Neurology · doi:10.1177/08830738060210062201 · Cited by 121
Targeting survivin in cancer: the cell-signalling perspective
Kanwar, J. R., Kamalapuram, S. K., & Kanwar, R. K. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.04.001 · Cited by 120
Topolnik, L., Azzi, M., Morin, F., Kougioumoutzakis, A., & Lacaille, J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.112896 · Cited by 118
Pelkey, K. A., Topolnik, L., Lacaille, J.-C., & McBain, C. J. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.032 · Cited by 115
Current development of the second generation of mTOR inhibitors as anticancer agents
Zhou, H., & Huang, S. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10281 · Cited by 115
Disorders of glutamate metabolism
Kelly, A. T., & Stanley, C. A. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1040 · Cited by 98
Scaffold protein Homer 1: Implications for neurological diseases
Luo, P., Li, X., Fei, Z., & Poon, W. S. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.06.014 · Cited by 93
Faissner, A., Heck, N., Dobbertin, A., & Garwood, J. (2007) · Springer eBooks · doi:10.1007/0-387-30128-3_3 · Cited by 92
Willard, S. S., & Koochekpour, S. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6475 · Cited by 89
Self-citationTOR kinase complexes and cell migration
Liu, L., & Parent, C. A. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102090 · Cited by 87
Mateos, J. M., Benı́tez, R., Elezgarai, I., Azkue, J., Lázaro, E., Osorio, A., Bilbao, A., Doñate, F., Sarría, R., Conquet, F., et al. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741301.x · Cited by 83
Allen, J. W., Knoblach, S. M., & Faden, A. I. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400678 · Cited by 82
Therapeutic Promise and Principles: Metabotropic Glutamate Receptors
Maiese, K., Chong, Z. Z., Shang, Y., & Hou, J. (2008) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.1.1.6842 · Cited by 79
Kim, C. H., Braud, S., Isaac, J. T. R., & Roche, K. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502644200 · Cited by 78
Berthele, A., Laurie, D., Platzer, S., Zieglgänsberger, W., Tölle, T., & Sommer, B. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00670-2 · Cited by 75
Bailey, A. R., Giunta, B. N., Obregon, D. F., Nikolic, W. V., Tian, J., Sanberg, C. D., Sutton, D. T., & Tan, J. (2008) · PubMed · Cited by 73
Desai, M. A., Burnett, J. P., Mayne, N. G., et al. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10517-8 · Cited by 73
Schelman, W. R., Andres, R. D., Sipe, K. J., Kang, E., & Weyhenmeyer, J. A. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.06.011 · Cited by 70
Ramakers, G. M. J., Pasinelli, P., Hens, J. J. H., Gispen, W. H., & Graan, P. N. E. D. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00013-4 · Cited by 68
Functional diversity of excitatory amino acid transporters: ion channel and transport modes
Fairman, W. A., & Amara, S. G. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.4.f481 · Cited by 68
White matter synapses: Form, function, and dysfunction
Alix, J. J. P., & Domingues, A. M. D. J. (2011) · Neurology · doi:10.1212/wnl.0b013e3182088273 · Cited by 67
Lampinen, M., Pentikäinen, O. T., Johnson, M. S., & Keinänen, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4704 · Cited by 66
Glutamatergic signaling in cellular transformation
Teh, J. L. F., & Chen, S. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00983.x · Cited by 59
Hermans, E., Challiss, R. A. J., & Nahorski, S. R. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702359 · Cited by 54
HmGlu1d, a novel splice variant of the human type I metabotropic glutamate receptor.
Laurie, D. J., Boddeke, H., Hiltscher, R., & Sommer, B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00868-3 · Cited by 50
Costantino, G., & Pellicciari, R. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9601718 · Cited by 47
Chong, Z. Z., Kang, J., & Maiese, K. (2003) · PubMed · doi:10.14670/hh-18.173 · Cited by 46
Alsina, F. C., Ledda, F., & Paratcha, G. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12021 · Cited by 37
Selkirk, J. V., Price, G. W., Nahorski, S. R., & Challiss, R. A. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00208-2 · Cited by 36
Jiang, Y., Huang, Y., Wong, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.147033 · Cited by 34
Esseltine, J. L., Willard, M. D., Wulur, I. H., Lajiness, M. E., Barber, T. D., & Ferguson, S. S. G. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.081695 · Cited by 29
Pin, J., Gomeza, J., Joly, C., & Bockaert, J. (1995) · Biochemical Society Transactions · doi:10.1042/bst0230091 · Cited by 28
Calcium Dependence of Native Metabotropic Glutamate Receptor Signaling in Central Neurons
Tabata, T., & Kano, M. (2004) · Molecular Neurobiology · doi:10.1385/mn:29:3:261 · Cited by 24
Thomsen, C. (1996) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(96)00042-5 · Cited by 20
Venus Fly Trap Domain of mGluR1 Functions as a Dominant Negative Against Group I mGluR Signaling
Beqollari, D., & Kammermeier, P. J. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00799.2009 · Cited by 20
Laurie, D., Boddeke, H. W. G. M., Hiltscher, R., & Sommer, B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00144-6 · Cited by 17
Hiltscher, R., Seuwen, K., Boddeke, H., Sommer, B., & Laurie, D. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00079-3 · Cited by 17
Seebahn, A., Sticht, H., & Enz, R. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391861-1.00012-5 · Cited by 7
Cited by
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Pajarillo, E., Rizor, A., Lee, J., Aschner, M., & Lee, E. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.002 · Cited by 478
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“Group II (mGluR2, mGluR3) and Group III (mGluR4, mGluR6–mGluR8) are both coupled to Gi proteins inhibiting adenylate cyclase (AC) activity and expressed on pre- as well as postsynaptic sites (Willard & Koochekpour, 2013).”
BackgroundThe glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
Hu, W., MacDonald, M. L., Elswick, D. E., & Sweet, R. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12547 · Cited by 286
Metadata
- Authors
- Willard, S. S., & Koochekpour, S.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2013
- Volume
- 9
- Issue
- 9
- Pages
- 948-959
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W2154168677
- Cited by
- 323
- References
- 92
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.